Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Am J Dermatopathol. 2012 Apr;34(2):129–138. doi: 10.1097/DAD.0b013e3181ed39f9

Figure 3.

Figure 3

Most benign sebaceous neoplasms, such as this well-circumscribed sebaceoma (A), were not immunoreactive for p53 (B). A single sebaceoma from the cheek with lobular, benign architecture (C) showed strong p53 immunoreactivity (D).